ALT has 36-month beta value of 0.86. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for ALT is 76.22M, and currently, short sellers hold a 29.48% ratio of that float. The average trading volume of ALT on March 12, 2025 was 2.44M shares.
ALT) stock’s latest price update
Altimmune Inc (NASDAQ: ALT) has experienced a decline in its stock price by -3.57 compared to its previous closing price of 5.45. However, the company has seen a fall of -11.74% in its stock price over the last five trading days. globenewswire.com reported 2025-03-06 that Program to Feature Presentations from Renowned KOLs in Obesity, MASH and Two Additional Indications for Pemvidutide following recent IND Clearances by FDA Program to Feature Presentations from Renowned KOLs in Obesity, MASH and Two Additional Indications for Pemvidutide following recent IND Clearances by FDA
ALT’s Market Performance
Altimmune Inc (ALT) has seen a -11.74% fall in stock performance for the week, with a -21.02% decline in the past month and a -42.45% plunge in the past quarter. The volatility ratio for the week is 5.43%, and the volatility levels for the past 30 days are at 6.75% for ALT. The simple moving average for the last 20 days is -13.77% for ALT’s stock, with a simple moving average of -24.84% for the last 200 days.
Analysts’ Opinion of ALT
Stifel, on the other hand, stated in their research note that they expect to see ALT reach a price target of $18. The rating they have provided for ALT stocks is “Buy” according to the report published on January 08th, 2025.
UBS gave a rating of “Buy” to ALT, setting the target price at $26 in the report published on November 12th of the previous year.
ALT Trading at -20.59% from the 50-Day Moving Average
After a stumble in the market that brought ALT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -54.26% of loss for the given period.
Volatility was left at 6.75%, however, over the last 30 days, the volatility rate increased by 5.43%, as shares sank -20.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.33% lower at present.
During the last 5 trading sessions, ALT fell by -11.74%, which changed the moving average for the period of 200-days by -31.69% in comparison to the 20-day moving average, which settled at $6.10. In addition, Altimmune Inc saw -27.05% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALT starting from Drutz David, who sale 16,011 shares at the price of $6.90 back on Aug 19 ’24. After this action, Drutz David now owns 41,958 shares of Altimmune Inc, valued at $110,547 using the latest closing price.
Stock Fundamentals for ALT
Current profitability levels for the company are sitting at:
- -5158.6 for the present operating margin
- -7.4 for the gross margin
The net margin for Altimmune Inc stands at -4752.95. The total capital return value is set at -0.8. Equity return is now at value -59.86, with -54.33 for asset returns.
Based on Altimmune Inc (ALT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -47.5. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -11463.56.
Currently, EBITDA for the company is -94.81 million with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 18492.35. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.10.
Conclusion
To put it simply, Altimmune Inc (ALT) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
